Healthy volunteer profile: Levels of anxiety, depression, socioeconomic aspects and candidates' motivations of participation in phase I clinical trials

被引:0
|
作者
Salvatierra, Andree [1 ,2 ]
Lioba, Iris [2 ]
Perez, Marta [2 ]
Mateus, Julian [2 ]
Grau, Santiago [1 ,3 ]
Aldea-Perona, Ana [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, Barcelona, Spain
[2] Hosp del Mar Med Res Inst IMIM, Clin Trials Unit, Barcelona, Spain
[3] Hosp del Mar, Serv Hosp Pharm, Barcelona, Spain
来源
ANSIEDAD Y ESTRES-ANXIETY AND STRESS | 2020年 / 26卷 / 2-3期
关键词
Healthy volunteers; Phase I clinical trials; Motivation; Anxiety; Depression; SPANISH VERSION; VALIDATION; SCALE; RELIABILITY; ADAPTATION; VALIDITY;
D O I
10.1016/j.anyes.2020.03.003
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: Healthy volunteers participate in phase I clinical trials mainly in search of an economic compensation; their economic instability may constitute a vulnerability factor for anxiety/depression. Objectives: To select suitable and rapid screening tests for anxiety and depression in healthy volunteers, to know their socioeconomic situation and to identify the main reason for their participation. Methods: Cross-sectional study, under a nonparametric statistical analysis and ROC curve analysis. Goldberg's Anxiety and Depression Scale (GADS) (fast test) and the Beck Depression (BDI-II) and Anxiety (BAI) Inventories (standard tests) were applied to all participants. Results: One hundred and thirty-nine potential candidates were recruited; the average age was 32 years (SD = 8.8); 53.9% were students, 43.9% employers and 2.2% were unemployed; 85.6% had university studies, 13.7% secondary education and .7% primary studies. GADS, BDI-II and BAI results were: 24.5% volunteered with anxiety and 15.8% with depression (GADS); anxiety levels (BAI): 60.4% had null, 25.9% mild, 11.5% moderate and 2.2% severe; depression (BDI-II): 87.8% had null, 5.8% mild, 5.8% moderate and .7% severe. Socioeconomic characteristics: 48.2% low stratum, 43.2% medium, 5.7% medium high and 2.8% high. Motivations: 46.1% for economic compensation, 35.9% contribution to science, 14.4% for curiosity and 3.6% access to health. Conclusions: GADS shows insufficient capacity to discriminate between anxiety/depression and the use of BAI and BDI-II is suggested; anxiety and depression levels were higher in healthy volunteers than the prevalence in the general population but lower when compared to university population; employment status was mostly composed of university students with low socioeconomic characteristics and a high economic motivation. (C) 2020 Sociedad Espanola para el Estudio de la Ansiedad y el Estres - SEAS. Published by Elsevier Espafia, S.L.U. All rights reserved.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 14 条
  • [1] Interpersonal Values of Healthy Subjects Who Volunteer for Phase I Clinical Trials
    Luis Almeida
    Manuel Vaz-da-Silva
    Rui Coelho
    António Albino-Teixeira
    Patrício Soares-da-Silva
    Pharmaceutical Medicine, 2009, 23 (5-6) : 299 - 303
  • [2] Characteristics, Motivations, and Preferences of Healthy Volunteers in Phase I Clinical Trials in Sweden
    Rein-Hedin, Erik
    Schultzberg, Marten
    Sjoberg, Folke
    Huss, Fredrik
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2025,
  • [3] Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy
    Nurgat, ZA
    Craig, W
    Campbell, NC
    Bissett, JD
    Cassidy, J
    Nicolson, MC
    BRITISH JOURNAL OF CANCER, 2005, 92 (06) : 1001 - 1005
  • [4] Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy
    Z A Nurgat
    W Craig
    N C Campbell
    J D Bissett
    J Cassidy
    M C Nicolson
    British Journal of Cancer, 2005, 92 : 1001 - 1005
  • [5] Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials
    Fisher, Jill A.
    McManus, Lisa
    Wood, Megan M.
    Cottingham, Marci D.
    Kalbaugh, Julianne M.
    Monahan, Torin
    Walker, Rebecca L.
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2018, 13 (05) : 494 - 510
  • [6] Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials
    Manton, Kerry J.
    Gauld, Cassandra S.
    White, Katherine M.
    Griffin, Paul M.
    Elliott, Suzanne L.
    BMJ OPEN, 2019, 9 (01):
  • [7] Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy.
    Nurgat, Z
    PHARMACOTHERAPY, 2005, 25 (10): : 1468 - 1468
  • [8] Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time
    Kalbaugh, Corey A.
    Kalbaugh, Julianne M.
    McManus, Lisa
    Fisher, Jill A.
    PLOS ONE, 2021, 16 (09):
  • [9] "My Body is One of the Best Commodities" Exploring the Ethics of Commodification in Phase I Healthy Volunteer Clinical Trials
    Walker, Rebecca L.
    Fisher, Jill A.
    KENNEDY INSTITUTE OF ETHICS JOURNAL, 2019, 29 (04) : 305 - 331
  • [10] Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes
    Deiteren, Annemie
    Coenen, Erwin
    Lenders, Sabine
    Verwilst, Peter
    Mannaert, Erik
    Rasschaert, Freya
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (06): : 2450 - 2460